Cleaved caspase-8, the activated form of caspase-8, significantly increased in 50 μM embelin treatment of three breast cancer cell lines and increased only in 25 μM embelin-treated MDA-MB-231 (Fig. 3a–f). Here, CASP8 is linked to breast cancer.